Development of a biomarker panel for assessing cardiovascular risk in diabetic patients with chronic limb-threatening ischemia (CLTI): a prospective study

Development of a biomarker panel for assessing cardiovascular risk in diabetic patients with chronic limb-threatening ischemia (CLTI): a prospective study

Abstract Background Lower-extremity endovascular revascularization (LER) is often required for diabetic patients with chronic limb threatening ischemia (CLTI). During the post-revascularization period patients may unpredictably experience major adverse cardiac events (MACE) and major adverse limb ev...

Full description

Bibliographic Details
Main Authors: Elisabetta Nardella, Federico Biscetti, Maria Margherita Rando, Andrea Leonardo Cecchini, Maria Anna Nicolazzi, Enrica Rossini, Flavia Angelini, Roberto Iezzi, Luis H. Eraso, Paul J. Dimuzio, Dario Pitocco, Massimo Massetti, Antonio Gasbarrini, Andrea Flex
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Cardiovascular Diabetology
Subjects:
Peripheral artery disease (PAD)
Chronic limb threatening ischemia (CLTI)
Major adverse cardiac events (MACE)
Major adverse limb events (MALE)
Biomarkers
Online Access:https://doi.org/10.1186/s12933-023-01872-x

Internet

https://doi.org/10.1186/s12933-023-01872-x

Similar Items